Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Instructions to Pick the Best Course for Your Next Waterway Voyage: Objections, Views, and Social Encounters - 2Germany's Merz under fire in Brazil for his comments on Amazon host city of COP30
- 3'Israel has the right to continue its attacks,' Lebanese Foreign Minister announces
- 45 Great Crossover Vehicles For Eco-friendliness In 2024
- 5Becoming Familiar with an Unknown dialect: My Language Learning Excursion
- I traveled to 13 countries in 2025. This small island nation surprised me the most.
- Washington resident contracts bird flu, first human case in U.S. since February
- The Excursion to Monetary Proficiency: Individual budget Triumphs
- Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday
- The 10 Most Persuasive Forerunners in Innovation
- Can ICE agents detain U.S. citizens? What powers do they have to arrest people? Your most common questions answered.
- Figure out How to Back Your Rooftop Substitution
- Pfizer says patient dies after receiving hemophilia drug in trial
- Director Emerald Fennell explains why "Wuthering Heights" has quotation marks around the title
